Manufacturing Mix Expansion
Manufacturing accounted for 37.5% of revenues in 2025, up from 36% in 2024 and from just over 25% in 2020 — demonstrating multi-year progress toward higher-value, higher-utilization production applications.
Strategic Aerospace & Defense Wins and Scale Production
Transformational partnership with Airbus (25,000 flight-ready parts produced last year; >200,000 certified Stratasys parts in active service) and multiple wins with Boeing and other OEMs, demonstrating production-scale additive manufacturing with claims of up to 43% weight reduction and 85% lead time reduction.
Notable Automotive and High-Utilization Deployments
Major customer deployments: Subaru adoption of the T25 head yielding >50% tooling development time reduction, 70% prototyping/tooling cost reduction and ~2x print speed; Rivian deployed 28 systems with F900 >90% utilization and F3300s processing ~6,000 requests annually.
Partnerships and Ecosystem Expansion
New partnerships and integrations announced with nTop (validated FDM workflow integration), PostProcess (automated post-processing distribution) and Oak Ridge Systems (expanded channel for PolyJet, SLA, P3), strengthening end-to-end workflow offerings.
Positive Adjusted EBITDA and EPS (Non-GAAP)
Q4 adjusted EBITDA of $9.2M (6.6% margin) and adjusted EPS of $0.07; full-year 2025 adjusted EBITDA of $28.5M (5.2% of revenue), up from $26.0M (4.5%) in 2024, and non-GAAP net income of $12.7M ($0.15 per share) vs $4.2M ($0.06) in 2024.
Cost Discipline and Operating Expense Improvement
Non-GAAP operating expenses decreased in absolute terms (Q4 $60.8M vs $65.2M prior year) and were down ~ $26.7M year-over-year for 2025; full-year non-GAAP OpEx as % of revenue improved to 45.4% from 48.4% in 2024, reflecting restructuring and cost-saving initiatives.
Improved Annual Cash Generation and Strong Balance Sheet
Generated $15.1M of cash from operations in 2025 (vs $7.8M in 2024). Ended year with $244.5M in cash, equivalents and short-term deposits and no debt, providing financial flexibility for organic investment and M&A.